Information regarding polypill treatment is lacking

Kidney Int. 2023 Jun;103(6):1201. doi: 10.1016/j.kint.2023.02.025.

Authors

Inès Dufour¹, Arnaud Devresse²

Affiliations

¹ Division of Nephrology, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium.
² Division of Nephrology, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium. Electronic address: arnaud.devresse@uclouvain.be.

PMID: 37210198
DOI: 10.1016/j.kint.2023.02.025

No abstract available

Publication types

Letter
Comment

MeSH terms

Antihypertensive Agents / therapeutic use
Cardiovascular Diseases* / drug therapy
Drug Combinations
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors*

Substances

Antihypertensive Agents
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Drug Combinations